BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 32298798)

  • 1. Covalent fragment libraries in drug discovery.
    Keeley A; Petri L; Ábrányi-Balogh P; Keserű GM
    Drug Discov Today; 2020 Jun; 25(6):983-996. PubMed ID: 32298798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covalent fragment-based drug discovery for target tractability.
    McCarthy WJ; van der Zouwen AJ; Bush JT; Rittinger K
    Curr Opin Struct Biol; 2024 Jun; 86():102809. PubMed ID: 38554479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Covalent fragment libraries in drug discovery-Design, synthesis, and screening methods.
    Hocking B; Armstrong A; Mann DJ
    Prog Med Chem; 2023; 62():105-146. PubMed ID: 37981350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABPP-CoDEL: Activity-Based Proteome Profiling-Guided Discovery of Tyrosine-Targeting Covalent Inhibitors from DNA-Encoded Libraries.
    Jiang L; Liu S; Jia X; Gong Q; Wen X; Lu W; Yang J; Wu X; Wang X; Suo Y; Li Y; Uesugi M; Qu ZB; Tan M; Lu X; Zhou L
    J Am Chem Soc; 2023 Nov; 145(46):25283-25292. PubMed ID: 37857329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An electrophilic warhead library for mapping the reactivity and accessibility of tractable cysteines in protein kinases.
    Petri L; Egyed A; Bajusz D; Imre T; Hetényi A; Martinek T; Ábrányi-Balogh P; Keserű GM
    Eur J Med Chem; 2020 Dec; 207():112836. PubMed ID: 32971426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Where Do Recent Small Molecule Clinical Development Candidates Come From?
    Brown DG; Boström J
    J Med Chem; 2018 Nov; 61(21):9442-9468. PubMed ID: 29920198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fragment-based lead discovery and design.
    Joseph-McCarthy D; Campbell AJ; Kern G; Moustakas D
    J Chem Inf Model; 2014 Mar; 54(3):693-704. PubMed ID: 24490951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fragment-based screening with natural products for novel anti-parasitic disease drug discovery.
    Liu M; Quinn RJ
    Expert Opin Drug Discov; 2019 Dec; 14(12):1283-1295. PubMed ID: 31512943
    [No Abstract]   [Full Text] [Related]  

  • 9. From fragment screening to potent binders: strategies for fragment-to-lead evolution.
    Eitner K; Koch U
    Mini Rev Med Chem; 2009 Jul; 9(8):956-61. PubMed ID: 19601891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fragment-based approaches to the discovery of kinase inhibitors.
    Mortenson PN; Berdini V; O'Reilly M
    Methods Enzymol; 2014; 548():69-92. PubMed ID: 25399642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Covalent Small Molecules as Enabling Platforms for Drug Discovery.
    Dalton SE; Campos S
    Chembiochem; 2020 Apr; 21(8):1080-1100. PubMed ID: 31833626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Tractable Cysteines for Covalent Targeting by Screening Covalent Fragments.
    Petri L; Ábrányi-Balogh P; Tímea I; Pálfy G; Perczel A; Knez D; Hrast M; Gobec M; Sosič I; Nyíri K; Vértessy BG; Jänsch N; Desczyk C; Meyer-Almes FJ; Ogris I; Golič Grdadolnik S; Iacovino LG; Binda C; Gobec S; Keserű GM
    Chembiochem; 2021 Feb; 22(4):743-753. PubMed ID: 33030752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophilic warheads in covalent drug discovery: an overview.
    Péczka N; Orgován Z; Ábrányi-Balogh P; Keserű GM
    Expert Opin Drug Discov; 2022 Apr; 17(4):413-422. PubMed ID: 35129005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA-encoded chemical libraries: advancing beyond conventional small-molecule libraries.
    Franzini RM; Neri D; Scheuermann J
    Acc Chem Res; 2014 Apr; 47(4):1247-55. PubMed ID: 24673190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactivity of Covalent Fragments and Their Role in Fragment Based Drug Discovery.
    McAulay K; Bilsland A; Bon M
    Pharmaceuticals (Basel); 2022 Nov; 15(11):. PubMed ID: 36355538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteome-wide covalent ligand discovery in native biological systems.
    Backus KM; Correia BE; Lum KM; Forli S; Horning BD; González-Páez GE; Chatterjee S; Lanning BR; Teijaro JR; Olson AJ; Wolan DW; Cravatt BF
    Nature; 2016 Jun; 534(7608):570-4. PubMed ID: 27309814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting cancer using fragment based drug discovery.
    Turnbull AP; Boyd SM
    Anticancer Agents Med Chem; 2012 Jan; 12(1):40-8. PubMed ID: 21707503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Covalent docking of large libraries for the discovery of chemical probes.
    London N; Miller RM; Krishnan S; Uchida K; Irwin JJ; Eidam O; Gibold L; Cimermančič P; Bonnet R; Shoichet BK; Taunton J
    Nat Chem Biol; 2014 Dec; 10(12):1066-72. PubMed ID: 25344815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The application of small molecule bioactive probes in the identification of cellular targets].
    Zhang J; Zhou HC
    Yao Xue Xue Bao; 2012 Mar; 47(3):299-306. PubMed ID: 22645752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fragment-Based Drug Discovery for RNA Targets.
    Lundquist KP; Panchal V; Gotfredsen CH; Brenk R; Clausen MH
    ChemMedChem; 2021 Sep; 16(17):2588-2603. PubMed ID: 34101375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.